How do BPH and prostate cancer differ? Symptoms and diagnosis

Originally titled: “Benign Prostatic Hyperplasia vs Prostate Cancer

Channel: Dr Matt & Dr Mike · Watch on YouTube ↗

Published 5/13/2020 · Updated 8/15/2026

Best for: Men interested in understanding prostate health, especially those approaching middle age or experiencing urinary symptoms.
Be careful: The video advises viewers to seek professional medical evaluation for any prostate-related symptoms and does not replace personalized medical advice.

Summary

In the presentation, Dr. Matt begins by defining benign prostatic hyperplasia as a non‑cancerous enlargement of the prostate gland that commonly occurs with aging, whereas prostate cancer is described as a malignant growth of prostate cells that can metastasize. He contrasts the epidemiology of the two conditions, noting that BPH affects a majority of men over 50, while prostate cancer has a lower overall prevalence but a higher mortality risk if left untreated. The discussion moves to risk factors, highlighting age, family history, hormonal influences, and lifestyle elements such as diet and physical activity. Dr. Matt emphasizes that while many risk factors overlap, certain genetic mutations and high-grade prostatic intraepithelial neoplasia are more specific to cancer. Symptoms are compared next: BPH typically causes lower urinary tract symptoms like frequency, urgency, and weak stream, whereas prostate cancer may be asymptomatic early on and later present with hematuria, bone pain, or systemic signs. Diagnostic pathways are outlined, including digital rectal exam, PSA testing, ultrasound, and the role of MRI and biopsy for confirming cancer. Treatment options are summarized: BPH management often involves watchful waiting, medication (alpha‑blockers, 5‑alpha‑reductase inhibitors), or minimally invasive procedures, while prostate cancer treatment ranges from active surveillance for low‑risk disease to surgery, radiation, hormonal therapy, and newer targeted agents for advanced cases. The video concludes with a brief Q&A, stressing the importance of regular screening, individualized risk assessment, and consulting a urologist for personalized care.

Key Takeaways

  • BPH is a benign enlargement of the prostate, while prostate cancer is a malignant condition with potential to spread.
  • Both conditions share some risk factors, but family history and specific genetic changes are more strongly linked to cancer.
  • Typical BPH symptoms involve urinary flow issues; prostate cancer may be silent early and present with systemic signs later.
  • Diagnostic work‑up includes physical exam, PSA testing, imaging, and biopsy when cancer is suspected.
  • Management strategies differ: BPH often uses medication or minimally invasive procedures, whereas prostate cancer may require surgery, radiation, hormonal therapy, or observation depending on risk level.

What to Be Careful About

  • The video advises viewers to seek professional medical evaluation for any prostate-related symptoms and does not replace personalized medical advice.

Enjoying this breakdown? Get one every week.

5 trending videos summarised · 3 claims checked · 1 practical takeaway — every week. No miracle-cure nonsense.

Health Claims in This Video

Topics

Key terms in this video

Related reviews

Are you the creator of this video?

Embed this badge on your site or in your video description to link back to our review.

Reviewed by MenHealth Digest

Free newsletter

Get the weekly digest

5 videos summarised · 3 claims checked · 1 practical takeaway

Unsubscribe any time. No spam.